This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Arfa, I. Articles by Abdelhak, S. Search for Related Content PubMed PubMed Citation Articles by Arfa, I. Articles by Abdelhak, S. Social Bookmarking                         What's this?

Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients

Molecular Investigation of Genetic Orphan Diseases Research Unit, Institut Pasteur de Tunis. Tunis, Tunisia

Abdelmajid Abid

National Institute of Nutrition, Tunis, Tunisia

Sonia Nouira

Molecular Investigation of Genetic Orphan Diseases Research Unit, Institut Pasteur de Tunis. Tunis, Tunisia, sonia.abdelhak @pasteur.rns.tn

Houda Elloumi-Zghal

Molecular Investigation of Genetic Orphan Diseases Research Unit, Institut Pasteur de Tunis. Tunis, Tunisia

Dhafer Malouche

Engineering school of statistic and information analysis (LEGI-EPT-ESSAIT), University of 7th November at Carthage Tunis, Tunisia

Imen Mannai

Molecular Investigation of Genetic Orphan Diseases Research Unit, Institut Pasteur de Tunis. Tunis, Tunisia, Engineering school of statistic and information analysis (LEGI-EPT-ESSAIT), University of 7th November at Carthage Tunis, Tunisia

Mohamed Majdi Zorgati

Molecular Investigation of Genetic Orphan Diseases Research Unit, Institut Pasteur de Tunis. Tunis, Tunisia

Nissaf Ben Alaya

Laboratory of Epidemiology. Institut Pasteur de Tunis, Tunis, Tunisia

Ahmed Rebai

Center of Biotechnology Sfax, Tunisia

Béchir Zouari

Department of Epidemiology and Statistics, School University of Medicine, Tunis, Tunisia

Slim Ben Ammar

Molecular Investigation of Genetic Orphan Diseases Research Unit, Institut Pasteur de Tunis. Tunis, Tunisia

Mohamed Chiheb Ben Rayana

National Institute of Nutrition, Tunis, Tunisia

Slama Hmida

National Center of Blood Transfusion Tunis, Tunisia

Samira Blousa-Chabchoub

National Institute of Nutrition, Tunis, Tunisia

Sonia Abdelhak

Molecular Investigation of Genetic Orphan Diseases Research Unit, Institut Pasteur de Tunis. Tunis, Tunisia

Objective. The aim of the present study was to investigate whether the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism is associated with diabetic nephropathy and type 2 diabetes in the Tunisian population.

Design. A case-control study was conducted among 141 unrelated type 2 diabetic patients with (90 patients) or without nephropathy (51 patients) and 103 non-diabetic controls with normal fasting blood glucose. Genotyping was performed using a nested polymerase chain reaction amplification in order to identify correctly heterozygous individuals.

Results. The distribution of DD, ID and II genotypes did not significantly differ between type 2 diabetic patients with or without nephropathy (DD: 44%; ID: 46%; II: 10% vs. DD: 41%; ID: 47 %; II: 12%, respectively).There was also no significant statistical difference between the genotype distribution and allele frequencies of the (I/D) polymorphism in all type 2 diabetic subjects compared to non-diabetic controls with normal fasting blood glucose (DD: 43%; ID: 46%; II: 11% vs. DD: 37%; ID: 48% ;II: 15%, respectively).

Conclusions. In the present preliminary study, the (I/D) polymorphis within the ACE gene is likely not associated with diabetic nephropathy nor with type 2 diabetes in the Tunisian studied population.

Key Words: angiotensin-converting enzyme • diabetic nephropathy • insertion-deletion polymorphism • type 2 diabetes

References

• De Silva SNT, Weerasuriya N., De Alwis NM, De Silva MW, Fernando DJ Excess maternal transmission and familial aggregation of Type 2 diabetes in Sri Lanka. Diabetes Res Clin Pract 2002;58:173-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Barnett AH, Eff C., Leslie RD, Pyke DA Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981;20:87-93.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rossing P., Rossing K., Jacobsen P., Parving HH Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 1995;44:739-43.[Abstract]
• Freedman BI, Tuttle AB, Spray BJ Familial predisposition to nephropathy in African-Americans with non-insulin -
• dependent diabetes mellitus. Am J Kidney Dis 1995;25:710-71. 5. Faronato PP, Maioli M., Tonolo G. et al. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group. Diabetologia 1997;40:816-23.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wong TY, Poon P., Szeto CC, Chan JC, Li PK Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int 2000;57:632-8.[Web of Science][Medline] [Order article via Infotrieve]
• Hansen PM, Chowdhury T., Deckert T., Hellgren A., Bain SC, Pociot F. Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene). Association with urinary albumin excretion in IDDM patients. Diabetes 1997;46:1658-9.[Web of Science][Medline] [Order article via Infotrieve]
• Chowdhury TA, Dyer PH, Kumar S. et al. Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 1998;47:278-80.[Web of Science][Medline] [Order article via Infotrieve]
• Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 1977;233:366-72.
• Hostetter TH, Troy JL, Brenner BM Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981;19:410-15.[Web of Science][Medline] [Order article via Infotrieve]
• Ballerman BJ, Zeidel ML, Gunning ME, Brenner BM (1991). Vasoactive peptides and the kidney. In The Kidney. 4th ed. Brenner BM, Rector FC, Eds. Philadelphia, Saunders, p. 510-83.
• Erdos EG Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990;16:363-70.[Abstract/Free Full Text]
• Zatz R., Dunn BR, Meyer TW, Anderson S., Rennke HG, Brenner BM Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-30.[Web of Science][Medline] [Order article via Infotrieve]
• Marre M., Chatellier G., Leblanc H., Guyene TT, Menard J., Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988;297:1092-5.[Abstract/Free Full Text]
• Lewis EJ, Hunsicker LG, Bain RP, Rohde RD The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456-62.[Abstract/Free Full Text]
• Jauch KW, Hartl W., Guenther B., Wicklmayr M., Rett K., Dietze G. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1987;17:448-54.[Web of Science][Medline] [Order article via Infotrieve]
• Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.[Web of Science][Medline] [Order article via Infotrieve]
• Tiret L., Rigat B., Visvikis S. et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:97-205.
• Hadjadj S., Gallois Y., Alhenc-Gelas F. et al. Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients. Diabet Med 2003;20:677-82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hsieh MC, Lin SR, Hsieh TJ et al. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 2000;15:1008-13.[Abstract/Free Full Text]
• Schmidt S., Schone N., Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 1995;47:1176-81.[Web of Science][Medline] [Order article via Infotrieve]
• Singh PP, Naz I., Gilmour A., Singh M., Mastana S. Association of APOE (Hha1) and ACE (I/D) gene polymorphisms with type 2 diabetes mellitus in North West India. Diabetes Res Clin Pract 2006;74:95-102.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Feng Y., Niu T., Xu X. et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 2002;51:1986-8.[Abstract/Free Full Text]
• Grammer TB, Renner W., Von Karger S., Boehm BO, Winkelmann BR, Maerz W. The angiotensin-I converting enzyme I/D polymorphism is not associated with type 2 diabetes in individuals undergoing coronary angiography. (The Ludwigshafen Risk and Cardiovascular Health Study). Mol Genet Metab 2006;88:378-83.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Marre M., Jeunemaitre X., Gallois Y. et al. Contribution of Genetic Polymorphism in the Renin-Angiotensin System to the development of Renal Complications in Insulindependent diabetes. J Clin Invest 1997;99:1585-95.[Web of Science][Medline] [Order article via Infotrieve]
• Huang W., Gallois Y., Bouby N. et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. D Proc Natl Acad Sci USA 2001;98:1330-4.[CrossRef]
• Zingone A., Dominijanni A., Mele E. et al. Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum Genet 1994;94:207-09.[Web of Science][Medline] [Order article via Infotrieve]
• Rebai M., Kharrat N., Ayadi I., Rebai A. Haplotype structure of five SNPs within the ACE gene in the Tunisian population. Ann Hum Biol 2006;33:319-29.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Solini A., Vestra M., Saller A., Nosadini R., Crepaldi G., Fioretto P. The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes 2002;51:251-5.[Medline] [Order article via Infotrieve]
• Crook ED, Genous L., Oliver B. Angiotensin-converting enzyme genotype in blacks with diabetic nephropathy: effects on risk of diabetes and its complications. J Investig Med 2003;51:360-5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Shestakova MV, Vikulova OK, Gorashko NM et al. The relationship between genetic and haemodynamic factors in diabetic nephropathy (DN): Case-control study in type 1 diabetes mellitus (T1DM). Diabetes Res Clin Pract 2006 [Epub ahead of print].
• Buraczynska M., Ksiazek P., Lopatynski J., Spasiewicz D., Nowicka T., Ksiazek A. Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes. Pol Arch Med Wewn 2002;108:725-30.[Medline] [Order article via Infotrieve]
• Ng DP, Tai BC, Koh D., Tan KW, Chia KS Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 2004;48:1008-16.[CrossRef][Web of Science]
• Hadjadj S., Belloum R., Bouhanick B. et al. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. J Am Soc Nephrol 2001;12:541-9.[Abstract/Free Full Text]
• Schmidt S., Strojek K., Grzeszczak W., Bergis K., Ritz E. Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1997;12:427-9. 36. Parving HH, Jacobsen P., Tarnow L. et al. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition H of angiotensin converting enzyme: observational follow up study. BMJ 1996;313:591-4.[Abstract/Free Full Text]
• Penno G., Chaturvedi N., Talmud PJ et al. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes 1998;47:1507-11.[Abstract/Free Full Text]
• So WY, Ma RC, Ozaki R. et al. Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-interaction with ACE insertion/deletion polymorphism. Kidney Int 2006;69:1438-43.[Web of Science][Medline] [Order article via Infotrieve]
• Stephens JW, Dhamrait SS, Cooper JA et al. The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab 2005;84:83-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Huang XH, Rantalaiho V., Wirta O. et al. Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM. Hum Genet 1998;102:372-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Torlone E., Rambotti AM, Perriello G. et al. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 1991; 34:119-25.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Aguilar D., Solomon SD ACE-inhibitors and angiotensin receptor antagonists and the incidence of new-onset diabetes mellitus: an emerging theme. Drugs 2006;66:1169-77.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 9, No. 1, 32-36 (2008)
DOI: 10.3317/jraas.2008.002


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Nikzamir, A. Esteghamati, M. Feghhi, M. Nakhjavani, A. Rashidi, and Javad Zavar Reza The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes Journal of Renin-Angiotensin-Aldosterone System, June 1, 2009; 10(2): 109 - 114. [Abstract] [PDF]

				T. Baroudi, R. Bouhaha, C. Moran-Moguel, J. Sanchez-Corona, H. Ben Maiz, H. Kammoun Abid, and A. Benammar-Elgaaied Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia Journal of Renin-Angiotensin-Aldosterone System, March 1, 2009; 10(1): 35 - 40. [Abstract] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Arfa, I. Articles by Abdelhak, S. Search for Related Content PubMed PubMed Citation Articles by Arfa, I. Articles by Abdelhak, S. Social Bookmarking                         What's this?